Nycomed is a Takeda company since October 2011. Takeda is a research-based global company with its main focus on pharmaceuticals. The combined company has an active commercial presence in the therapeutic areas of metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain management.
Takeda’s traditional strengths in North America, Japan, and the rest of Asia, are now complemented by Nycomed’s position in Europe and the high growth emerging markets. It is present in more than 70 countries worldwide, and ranked 12th by global Rx sales, 14th in the BRIC countries and 18th in Europe.
As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better
health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.